This work demonstrates anti-cancer effects and catalytic abilities of a graphene-chitosan/gold nanocomposite, highlighting its potential applications.
This work describes a simple and environmentally friendly process for creating a graphene-chitosan/gold (GO-CS/Au) nanocomposite. This green synthesis method includes the reduction of gold ions onto graphene oxide that had previously been functionalized with chitosan, using pomegranate juice as a bio-reductant and capping agent. The pomegranate juice’s natural polyphenolic components helped to stabilize and reduce gold nanoparticles (AuNPs) on the GO-CS surface. To verify the GO-CS/Au nanocomposite’s successful synthesis and structure, a wide range of analytical methods were used. These techniques included X-ray diffraction (XRD), transmission electron microscopy (TEM), inductively coupled plasma (ICP) analysis, energy-dispersive X-ray spectroscopy (EDX) with elemental mapping, and field-emission scanning electron microscopy (FE-SEM). GO-CS/Au nanocomposite was subsequently assessed in vitro for biological applications. Using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, its potential as an anti-cancer drug was evaluated against two bladder cancer cell lines, 5637 and transitional cell carcinoma, SUPINSKI (TCCSUP). The nanocomposite reduced cell viability in a dose-dependent manner; it’s computed IC 50 values were 458 and 648 µg mL -1 , respectively. The antioxidant capacity of the GO-CS/Au nanocomposite was also investigated via the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay, which revealed a notable antioxidant activity with an IC 50 value of 98 µg mL -1 . Furthermore, chemical catalysis of the material was explored in the reduction of different nitroarenes with sodium borohydride, being monitored over UV-Vis. The material demonstrated excellent reusability, holding onto roughly 85% of its conversion efficiency after seven runs.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: